Rapid Micro Biosystems RPID Cash Flow Statement (2020-2026)

NASDAQ RPID
$1.66 -0.04 (-2.35%)
As of: Aug 20, 2026 · 3:59 PM EDT
Cash Flow Statement Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Operating Activities
Net Income (Quarter)
-24.99M-14.61M-14.93M-13.10M-16.34M-16.46M-13.89M-14.02M-13.39M-11.17M-13.32M-12.58M-11.32M-9.67M-11.26M-11.86M-11.51M-12.50M-14.28M-12.92M
Share-based Compensation (Quarter)
6.20M0.68M6.93M1.26M-4.69M4.69M1.24M1.23M-2.33M4.60M1.08M1.17M-2.26M1.04M-0.62M0.00M3.61M1.22M1.32M
Gains from Investment Securities (Quarter)
8.16M-0.17M-0.07M-0.05M
Asset Writedowns and Impairment (Quarter)
0.01M0.02M0.05M0.17M0.11M0.03M0.03M0.07M0.23M-0.22M0.43M0.69M0.01M
Cash from Operations (Quarter)
-19.31M-12.89M-16.80M-14.99M-15.11M-11.65M-16.69M-9.19M-9.71M-9.50M-15.53M-10.12M-8.60M-9.91M-9.06M-9.70M-9.05M-3.25M-15.06M-12.70M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles (Quarter)
-0.00M-0.01M0.03M
Amortization of Deferred Charges (Quarter)
0.10M0.07M0.09M0.10M
Depreciation & Amortization (CF) (Quarter)
0.40M0.45M0.56M0.68M0.73M0.86M0.76M0.77M0.78M0.79M0.81M0.83M0.86M0.87M0.85M0.81M0.80M0.79M0.71M0.67M
Change in Working Capital
Change in Receivables (Quarter)
1.95M-0.00M-1.17M0.26M0.56M0.71M0.14M-2.06M0.45M1.62M-0.61M0.09M-1.27M3.78M-3.00M1.53M-0.62M-2.30M3.23M-0.85M
Change in Inventory (Quarter)
2.26M1.52M2.04M3.63M-0.20M0.37M-0.21M-0.00M-0.75M-0.23M0.54M1.02M-0.18M-1.05M1.07M0.04M0.51M-3.10M-0.14M1.83M
Change in Account Payables (Quarter)
-0.32M1.69M-0.37M-0.75M0.85M1.76M-4.14M0.08M1.91M-1.30M-0.81M1.02M0.15M0.20M0.10M0.70M0.25M0.55M0.53M0.41M
Change in Accured Expenses (Quarter)
1.27M-0.34M-3.88M-0.60M1.71M0.01M-1.61M1.19M-1.04M2.90M-3.10M0.51M-0.86M-0.44M-2.00M0.34M0.60M1.10M-2.23M-0.95M
Other Working Capital Changes (Quarter)
2.51M-1.45M-0.84M-1.11M2.10M-0.73M-0.37M-0.73M-0.72M1.54M0.41M-0.92M-0.26M0.36M-0.20M0.01M-0.08M-0.06M0.32M-0.40M
Investing Activities
Capital Expenditures (Quarter)
0.75M1.10M2.35M-1.97M5.55M-6.11M0.76M-0.53M-0.03M-0.21M0.58M-0.59M0.03M1.34M0.32M-0.24M0.68M-0.75M0.01M-0.22M
Change in Acquisitions & Divestments (Quarter)
25.00M30.00M37.50M32.50M22.50M-55.00M18.48M25.26M14.86M10.50M11.00M12.00M8.75M8.00M2.01M3.00M
Cash from Investing Activities (Quarter)
-0.46M-27.06M-99.55M2.21M-8.93M12.80M13.91M13.47M4.77M10.01M13.52M24.82M-6.54M4.86M10.68M9.34M-9.58M3.89M8.60M4.22M
Financing Activities
Other financing activities (Quarter)
-0.23M-0.28M0.47M-0.31M0.41M0.01M0.12M0.06M-0.00M0.17M0.06M0.09M0.33M-0.26M0.33M0.12M9.26M
Cash from Financing Activities (Quarter)
139.31M-1.26M0.46M-0.01M0.15M0.09M0.12M-0.01M0.05M-0.01M0.16M-0.01M0.06M-0.01M0.38M-0.30M19.25M0.44M0.25M9.35M
Change in Capital Stock
Net Equity Issued and Repurchased (Quarter)
Additional items
Change in Cash (Quarter)
119.54M-41.20M-115.89M-12.78M-23.89M1.23M-2.65M4.27M-4.89M0.50M-1.85M14.69M-15.08M-5.05M2.00M-0.65M0.61M1.08M-6.21M0.87M
Free Cash Flow (Quarter)
-20.06M-13.99M-19.15M-13.01M-20.65M-5.55M-17.45M-8.66M-9.68M-9.29M-16.11M-9.53M-8.63M-11.25M-9.38M-9.46M-9.73M-2.50M-15.07M-12.48M
Net Cash Flow (Quarter)
119.54M-41.20M-115.89M-12.78M-23.89M1.23M-2.65M4.27M-4.89M0.50M-1.85M14.69M-15.08M-5.05M2.00M-0.65M0.61M1.08M-6.21M0.87M